| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,533 |
6,061 |
$568K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
779 |
569 |
$59K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
577 |
522 |
$48K |
| 87428 |
|
737 |
668 |
$47K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,798 |
1,559 |
$46K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
497 |
446 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,214 |
2,036 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
839 |
763 |
$30K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
527 |
421 |
$27K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
313 |
201 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
944 |
720 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
244 |
221 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
139 |
132 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
534 |
218 |
$10K |
| 90686 |
|
880 |
825 |
$7K |
| 87807 |
|
530 |
461 |
$5K |
| 90651 |
|
177 |
140 |
$5K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
54 |
43 |
$4K |
| 90734 |
|
137 |
91 |
$3K |
| 96127 |
|
191 |
190 |
$3K |
| 0002A |
|
66 |
65 |
$3K |
| 0001A |
|
60 |
59 |
$3K |
| 90670 |
|
282 |
175 |
$2K |
| 90698 |
|
259 |
172 |
$2K |
| 0071A |
|
30 |
30 |
$1K |
| 90715 |
|
72 |
54 |
$1K |
| 0072A |
|
29 |
29 |
$1K |
| 90619 |
|
59 |
57 |
$985.89 |
| 90685 |
|
153 |
121 |
$960.00 |
| 90710 |
|
82 |
54 |
$947.14 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$615.16 |
| 90656 |
|
24 |
23 |
$401.04 |
| 90744 |
|
19 |
12 |
$121.60 |
| 90680 |
|
14 |
13 |
$89.60 |
| 90633 |
|
12 |
12 |
$76.80 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
388 |
298 |
$0.00 |
| 90461 |
|
94 |
75 |
$0.00 |